Continuous glucose monitors (CGMs), insulin pumps and insulin pump consumables: Procurement status
Find the latest information on Pharmac’s procurement process for continuous glucose monitoring (CGM) devices, insulin pumps and insulin pump consumables.
Latest update
We met with our Diabetes Advisory Committee on Friday 21 June to consider some of the aspects of the proposal as well as some of the new information we have gathered since the close of the consultation. We intend to publish the record of this meeting as soon as possible while we work to finalise the funding proposal.
We have also met with the organiser of the petition and a number of groups within Health New Zealand | Te Whatu Ora, including the Long Term Conditions, and Data and Digital teams.
When we have confirmed the date of the Board meeting where this proposal would be considered, we will update this page. We understand people would like to know more as soon as possible.
Online information session
Pharmac hosted an online information session to talk about the process of developing the funding proposal and provide an update on Pharmac’s next steps, including engagement with clinicians, consumers, and suppliers.
Timing of the procurement process
Pharmac initially signalled interest in funding CGMs and considering the supply of insulin pumps and insulin pump consumables in February 2023.
We understand people would like to know how long this procurement process will take. Below we have noted the milestones we have worked to so far.
Unfortunately, the time required to undertake procurement processes can vary. As such, we can’t be certain about future timings. However, we will share updates on this webpage as more information becomes available.
Milestone | Date |
---|---|
FPO release | Complete (February 2023) |
Clinical advice | Complete (April 2023) |
Publishing records of clinical advice from the diabetes Specialist Advisory Committee | Complete (July 2023) |
RFP release | Complete (July 2023) |
Supplier briefing | Complete (July 2023) |
Stakeholder briefing | Complete (August 2023) |
Bids close | Complete (August 2023) |
Evaluation committee meetings and seeking further clinical advice | Complete (November 2023) |
Contracting with preferred suppliers | Complete (March 2024) |
Consultation period | Complete (April 2024) |
Post-consultation delay announced |
Complete (21 May 2024) |
Groups we’ve met with
|
Complete (May–June 2024) |
Online information session | Complete (June 2024) |
Advisory Committee meeting |
Complete (June 2024) |
Stakeholder meetings
|
In progress (July 2024) |
Pharmac Board meeting | By the end of 2024 |
Decision notification date | To be confirmed |
Implementation date | To be confirmed |
The funding process
We had previously received funding applications for Dexcom, FreeStyle Libre and Medtronic CGMs. Applications Pharmac received prior to this process:
We received bids from a number of suppliers in response to the Request for Proposals (RFP) for the supply of CGMs, insulin pumps and insulin pump consumables. To assess these bids, we held three evaluation committee meetings, including clinical experts, consumer representatives, and Pharmac staff. Pharmac uses information gathered during the evaluation meetings, alongside the Factors for Consideration, to select the preferred suppliers.
Who to contact
We will update this page as more information becomes available.
If your question is not answered here, email enquiry@pharmac.govt.nz